Francesca Caparrotti1, Shao Hui Huang1, Lin Lu2, Scott V Bratman1, Jolie Ringash1, Andrew Bayley1, John Cho1, Meredith Giuliani1, John Kim1, John Waldron1,3, Aaron Hansen4, Li Tong1, Wei Xu2, Brian O'Sullivan1,3, Robert Wood5, David Goldstein3, Andrew Hope1. 1. Department of Radiation Oncology, the Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. 2. Department of Biostatistics, the Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. 3. Department of Otolaryngology-Head and Neck Surgery, the Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. 4. Division of Medical Oncology, the Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. 5. Department of Dental Oncology, Dentistry, Ocular and Maxillofacial Prosthetics, the Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Osteoradionecrosis (ORN) of the mandible is a late toxicity affecting patients treated with radiotherapy for head and neck malignancies. To the authors' knowledge, ORN has no standardized grading system and its reporting is based on retrospective findings in heterogeneous patient populations. The rate of ORN in the era of intensity-modulated radiotherapy (IMRT) still is unknown. METHODS: The authors report the incidence of ORN from prospectively collected data regarding 1196 patients who were diagnosed with squamous cell carcinoma of the oropharynx and treated with curative-intent IMRT, with or without concomitant systemic treatment, from January 2005 to December 2014. Each case of ORN was graded according to its severity. Clinical and dosimetric comparisons were performed between patients with ORN and a matched control cohort of patients without ORN. RESULTS: The actuarial rate of ORN of the mandible was 3% at 1 year, 5% at 3 years, and 7% at 5 years. On multivariable analysis, smoking (hazard ratio, 1.9; 95% confidence interval, 1.07-3.4 [P = .03]) and T classification (hazard ratio, 1.78; 95% confidence interval, 1.02-3.1 [P = .041]) were found to be statistically significant risk factors. The presence of cardiovascular comorbidities, use of bisphosphonates, and pre-IMRT dental extractions were found to be different between the matched cohorts. The mandibular volume receiving 50 grays (Gy) (in cm3 ) and the volume receiving 60 Gy (in cm3 ) were found to be associated with ORN on multivariable analysis in the matched cohort patients receiving an IMRT regimen of 2 Gy per fraction. CONCLUSIONS: ORN is relatively uncommon among patients with oropharyngeal carcinoma who are treated with IMRT, but continues to occur beyond 5 years after treatment. Modifiable risk factors that are associated with higher rates of ORN include smoking and the use of bisphosphonates. Minimizing the volumes of the mandible receiving >50 Gy or > 60 Gy also may have an effect on the ORN rate. Cancer 2017;123:3691-3700.
BACKGROUND: Osteoradionecrosis (ORN) of the mandible is a late toxicity affecting patients treated with radiotherapy for head and neck malignancies. To the authors' knowledge, ORN has no standardized grading system and its reporting is based on retrospective findings in heterogeneous patient populations. The rate of ORN in the era of intensity-modulated radiotherapy (IMRT) still is unknown. METHODS: The authors report the incidence of ORN from prospectively collected data regarding 1196 patients who were diagnosed with squamous cell carcinoma of the oropharynx and treated with curative-intent IMRT, with or without concomitant systemic treatment, from January 2005 to December 2014. Each case of ORN was graded according to its severity. Clinical and dosimetric comparisons were performed between patients with ORN and a matched control cohort of patients without ORN. RESULTS: The actuarial rate of ORN of the mandible was 3% at 1 year, 5% at 3 years, and 7% at 5 years. On multivariable analysis, smoking (hazard ratio, 1.9; 95% confidence interval, 1.07-3.4 [P = .03]) and T classification (hazard ratio, 1.78; 95% confidence interval, 1.02-3.1 [P = .041]) were found to be statistically significant risk factors. The presence of cardiovascular comorbidities, use of bisphosphonates, and pre-IMRT dental extractions were found to be different between the matched cohorts. The mandibular volume receiving 50 grays (Gy) (in cm3 ) and the volume receiving 60 Gy (in cm3 ) were found to be associated with ORN on multivariable analysis in the matched cohort patients receiving an IMRT regimen of 2 Gy per fraction. CONCLUSIONS: ORN is relatively uncommon among patients with oropharyngeal carcinoma who are treated with IMRT, but continues to occur beyond 5 years after treatment. Modifiable risk factors that are associated with higher rates of ORN include smoking and the use of bisphosphonates. Minimizing the volumes of the mandible receiving >50 Gy or > 60 Gy also may have an effect on the ORN rate. Cancer 2017;123:3691-3700.
Authors: Ana Gabriela Costa Normando; Maria Eduarda Pérez-de-Oliveira; Eliete Neves Silva Guerra; Márcio Ajudarte Lopes; André Caroli Rocha; Thaís Bianca Brandão; Ana Carolina Prado-Ribeiro; Luiz Alcino Monteiro Gueiros; Joel B Epstein; César Augusto Migliorati; Alan Roger Santos-Silva Journal: Support Care Cancer Date: 2022-06-17 Impact factor: 3.603
Authors: Kevin J Contrera; Steven B Chinn; Randal S Weber; Dianna Roberts; Jeffery N Myers; Stephen Y Lai; Carol M Lewis; Amy C Hessel; Ann M Gillenwater; Collin F Mulcahy; Peirong Yu; Matthew M Hanasono; Clifton D Fuller; Mark S Chambers; Mark E Zafereo Journal: Head Neck Date: 2022-03-03 Impact factor: 3.821
Authors: Benjamin D Lovin; Mike Hernandez; Hunter Elms; Jonathan S Choi; Nathan R Lindquist; Amy C Moreno; Marc-Elie Nader; Paul W Gidley Journal: Laryngoscope Date: 2021-07-20 Impact factor: 2.970
Authors: Steffen Auerswald; Stephan Schreml; Robert Meier; Alexandra Blancke Soares; Maximilian Niyazi; Sebastian Marschner; Claus Belka; Martin Canis; Frank Haubner Journal: Radiat Oncol Date: 2019-11-11 Impact factor: 3.481